These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 359210)

  • 21. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cessation of immunosuppression after renal transplantation.
    Uehling DT; Hussey JL; Weinstein AB; Wank R; Bach FH
    Surgery; 1976 Mar; 79(3):278-82. PubMed ID: 769214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
    J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful steroid withdrawal after long-term administration in renal transplant patients.
    Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
    Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
    Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
    Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-rosette forming cell numbers in the blood of human renal allograft recipients.
    Kelly GE; Sheil AG
    Clin Exp Immunol; 1977 Mar; 27(3):454-63. PubMed ID: 324670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of alternate-day steroids on renal transplant function. A controlled study.
    McDonald FD; Horensten ML; Mayor GB; Turcotte JG; Selezinka W; Schork MA
    Nephron; 1976; 17(6):415-29. PubMed ID: 796739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allograft survival in patients receiving anticonvulsant medications.
    Wassner SJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Fine RN
    Clin Nephrol; 1977 Jul; 8(1):293-7. PubMed ID: 328199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-induced glaucoma and cataract in renal transplant recipients.
    Ticho U; Durst A; Licht A; Berkowitz S
    Isr J Med Sci; 1977 Sep; 13(9):871-4. PubMed ID: 336581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
    Anderton JL; Fananapazir L; Eccleston M
    Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study.
    Jabs K; Sullivan EK; Avner ED; Harmon WE
    Transplantation; 1996 Jan; 61(1):31-6. PubMed ID: 8560569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term alternate day steroid therapy in renal transplantation. A controlled study.
    Dumler F; Levin NW; Szego G; Vulpetti AT; Preuss LE
    Transplantation; 1982 Aug; 34(2):78-82. PubMed ID: 6753268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternate-day prednisone therapy in recipients of renal allografts. Risk and benefits.
    Diethelm AG; Sterling WA; Hartley MW; Morgan JM
    Arch Surg; 1976 Aug; 111(8):867-70. PubMed ID: 782401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth and development of children with renal transplants. Use of alternate-day steroid therapy.
    McEnery PT; Gonzalez LL; Martin LW; West CD
    J Pediatr; 1973 Nov; 83(5):806-14. PubMed ID: 4582575
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone.
    Levin B; Hoppe RT; Collins G; Miller E; Waer M; Bieber C; Girinsky T; Strober S
    Lancet; 1985 Dec; 2(8468):1321-5. PubMed ID: 2866386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternate day steroids in renal transplant patients.
    Gelman ML; Delmonico FL; Fulton B; Re R; Cosimi AB
    Proc Clin Dial Transplant Forum; 1977; 7():126-33. PubMed ID: 356033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.